Monoclonal antibodies in diagnosis and therapy
- PMID: 2047874
- DOI: 10.1126/science.2047874
Monoclonal antibodies in diagnosis and therapy
Abstract
Monoclonal antibodies have been applied clinically to the diagnosis and therapy of an array of human disorders, including cancer and infectious diseases, and have been used for the modulation of immune responses. Effective therapy using unmodified monoclonal antibodies has, however, been elusive. Recently, monoclonal antibody-mediated therapy has been revolutionized by advances such as the definition of cell-surface structures on abnormal cells as targets for effective monoclonal antibody action, genetic engineering to create less immunogenic and more effective monoclonal antibodies, and the arming of such antibodies with toxins or radionuclides to enhance their effector function.
Similar articles
-
Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection.Annu Rev Immunol. 1992;10:675-704. doi: 10.1146/annurev.iy.10.040192.003331. Annu Rev Immunol. 1992. PMID: 1590999 Review.
-
Advances in monoclonal antibody therapy of cancer.Am J Med Sci. 1992 Sep;304(3):214-24. doi: 10.1097/00000441-199209000-00011. Am J Med Sci. 1992. PMID: 1476160 Review.
-
Medical applications of monoclonal antibodies.Revis Biol Celular. 1986;9:1-79. Revis Biol Celular. 1986. PMID: 3324213 Review.
-
Genetically engineered monoclonal antibodies armed with radionuclides.Year Immunol. 1993;7:205-12. Year Immunol. 1993. PMID: 8103951 Review. No abstract available.
-
Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.Anticancer Res. 1996 Mar-Apr;16(2):661-74. Anticancer Res. 1996. PMID: 8687112 Review.
Cited by
-
Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.J Clin Invest. 1992 Sep;90(3):945-52. doi: 10.1172/JCI115971. J Clin Invest. 1992. PMID: 1326002 Free PMC article.
-
Angiogenin antagonists prevent tumor growth in vivo.Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):442-6. doi: 10.1073/pnas.92.2.442. Proc Natl Acad Sci U S A. 1995. PMID: 7831307 Free PMC article.
-
Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods.Pharm Res. 2024 Apr;41(4):779-793. doi: 10.1007/s11095-024-03684-4. Epub 2024 Mar 22. Pharm Res. 2024. PMID: 38519813
-
Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy.J Funct Biomater. 2021 Dec 16;12(4):75. doi: 10.3390/jfb12040075. J Funct Biomater. 2021. PMID: 34940554 Free PMC article. Review.
-
The biotechnology and applications of antibody engineering.Mol Biotechnol. 1995 Apr;3(2):139-54. doi: 10.1007/BF02789110. Mol Biotechnol. 1995. PMID: 7620975 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical